News 22 February 2012 Embryonal cancers in Europe - Corrected Proof 20 February 2012 A randomized, dose–response, multicenter phase II study of radium-223 chloride for the palliation of painful bone metastases in patients with castration-resistant prostate cancer - Corrected Proof 20 February 2012 Does baseline total testosterone improve the yielding of prostate cancer screening? - Corrected Proof 20 February 2012 Optimisation of the tumour response threshold in patients treated with everolimus for metastatic renal cell carcinoma: Analysis of response and progression-free survival in the RECORD-1 study - Corrected Proof 20 February 2012 Trends of cutaneous squamous cell carcinoma in the Netherlands: Increased incidence rates, but stable relative survival and mortality 1989–2008 - Corrected Proof 17 February 2012 Comparison of quantum dot technology with conventional immunohistochemistry in examining aldehyde dehydrogenase 1A1 as a potential biomarker for lymph node metastasis of head and neck cancer - Corrected Proof 16 February 2012 TIS21/BTG2/PC3 enhances downregulation of c-Myc during differentiation of HL-60 cells by activating Erk1/2 and inhibiting Akt in response to all-trans-retinoic acid - Corrected Proof 15 February 2012 Prostate cancer-specific mortality after definitive radiation therapy: Who dies of disease? - Corrected Proof
